Ticker Details
Absci Corporation Common Stock
IPO Date:	July 22, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$398.48M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 4.36%
Avg Daily Range (30 D):	$0.10 | 3.57%
Avg Daily Range (90 D):	$0.13 | 3.80%

Institutional Daily Volume
Avg Daily Volume:	1.65M
Avg Daily Volume (30 D):	3.01M
Avg Daily Volume (90 D):	3.77M

Trade Size
Avg Trade Size (Sh.):	177
Avg Trade Size (Sh.) (30 D):	213
Avg Trade Size (Sh.) (90 D):	218

Institutional Trades
Total Institutional Trades:	284
Avg Institutional Trade:	$1.64M
Avg Institutional Trade (30 D):	$.75M
Avg Institutional Trade (90 D):	$1.09M
Avg Institutional Trade Volume:	.38M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.73M
Avg Closing Trade (30 D):	$.76M
Avg Closing Trade (90 D):	$1.17M
Avg Closing Volume:	413.99K

News

Oct 29, 2025 @ 8:05 PM Absci to Report Business Updates and Third Quarter... Source: Globe Newswire

Oct 27, 2025 @ 12:00 PM Absci to Participate in Upcoming Investor Conferen... Source: Absci Corporation

Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff

Oct 9, 2025 @ 3:00 PM Computer-Aided Drug Design (CADD) Market Competiti... Source: Towards Healthcare

Sep 11, 2025 @ 4:10 PM Absci Boosts AI-Powered Drug Discovery With Oracle... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.91	$-.2	$-.24
Diluted EPS	$-.91	$-.2	$-.24
Revenue	$2.82M	$.38M	$.59M
Gross Profit
Net Income / Loss	$-114.6M	$-28.71M	$-30.57M
Operating Income / Loss	$-119.05M	$-30.15M	$-31.39M
Cost of Revenue
Net Cash Flow	$-28.28M	$-28.42M	$-8.84M
PE Ratio